Immune control of herpes simplex virus during latency
- 31 August 2004
- journal article
- review article
- Published by Elsevier BV in Current Opinion in Immunology
- Vol. 16 (4), 463-469
- https://doi.org/10.1016/j.coi.2004.05.003
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- The Differential Requirement for Cyclin-Dependent Kinase Activities Distinguishes Two Functions of Herpes Simplex Virus Type 1 ICP0Journal of Virology, 2003
- Promyelocytic Leukemia Protein Mediates Interferon-Based Anti-Herpes Simplex Virus 1 EffectsJournal of Virology, 2003
- Quantitative Analysis of Herpes Simplex Virus Reactivation In Vivo Demonstrates that Reactivation in the Nervous System Is Not Inhibited at Early Times PostinoculationJournal of Virology, 2003
- Explant-Induced Reactivation of Herpes Simplex Virus Occurs in Neurons Expressing Nuclear cdk2 and cdk4Journal of Virology, 2002
- Role of IFN-γand Tumor Necrosis Factor-αin Herpes Simplex Virus Type 1 InfectionJournal of Interferon & Cytokine Research, 2002
- Neither LAT nor Open Reading Frame P Mutations Increase Expression of Spliced or Intron-Containing ICP0 Transcripts in Mouse Ganglia Latently Infected with Herpes Simplex VirusJournal of Virology, 2002
- The Cyclin-Dependent Kinase Inhibitor Roscovitine Inhibits the Transactivating Activity and Alters the Posttranslational Modification of Herpes Simplex Virus Type 1 ICP0Journal of Virology, 2002
- Stress-associated immunomodulation and herpes simplex virus infectionsMedical Hypotheses, 2001
- Interferon-induces expression of cyclin-dependent kinase-inhibitors p21WAF1 and p27Kip1 that prevent activation of cyclin-dependent kinase by CDK-activating kinase (CAK)Oncogene, 1998
- Interferon‐Modulated Expression of Genes Encoding the Nuclear‐Dot‐Associated Proteins Sp100 and Promyelocytic Leukemia Protein (PML)JBIC Journal of Biological Inorganic Chemistry, 1996